DMAC (DiaMedica Therapeutics) Change In Inventory: $0.00 Mil (TTM As of Mar. 2026)

What is DiaMedica Therapeutics Change In Inventory?

DiaMedica Therapeutics DMAC +2.35% 31 Change In Inventory is $0.00 Mil as of Mar. 2026. GuruFocus rates DMAC with a GF Score™ of 31/100. The stock has 2 warning signs investors should review.

DiaMedica Therapeutics's change in inventory for the quarter that ended in Mar. 2026 was $0.00 Mil. It means DiaMedica Therapeutics's inventory stayed the same from Dec. 2025 to Mar. 2026 .

DiaMedica Therapeutics's change in inventory for the fiscal year that ended in Dec. 2025 was $0.00 Mil. It means DiaMedica Therapeutics's inventory stayed the same from Dec. 2024 to Dec. 2025 .

DiaMedica Therapeutics's Total Inventories for the quarter that ended in Mar. 2026 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

DiaMedica Therapeutics (NAS:DMAC) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

DiaMedica Therapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

DiaMedica Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

DiaMedica Therapeutics's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=	N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DiaMedica Therapeutics Change In Inventory Related Terms

DiaMedica Therapeutics Change In Inventory Historical Data

* Premium members only.

The historical data trend for DiaMedica Therapeutics's Change In Inventory can be seen below:

DiaMedica Therapeutics Change In Inventory Chart

DiaMedica Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Change In Inventory

Get a 7-Day Free Trial

0.00

DiaMedica Therapeutics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Change In Inventory	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

31GF Score

DiaMedica Therapeutics Inc DMAC

Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

DiaMedica Therapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Frequently Asked Questions Learn more about Change In Inventory →

What does a Change In Inventory of $0.00 Mil mean?

DiaMedica Therapeutics (DMAC) has a Change In Inventory of $0.00 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for DiaMedica Therapeutics and its competitors.

Is DiaMedica Therapeutics' Change In Inventory too high?

DiaMedica Therapeutics' current Change In Inventory is $0.00 Mil. Overall, DiaMedica Therapeutics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.

How does DiaMedica Therapeutics' Change In Inventory compare to PRLD and RCKT?

DiaMedica Therapeutics' Change In Inventory of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Change In Inventory for a Biotechnology company?

A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Change In Inventory mean?

A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for DiaMedica Therapeutics and its competitors. DiaMedica Therapeutics's current Change In Inventory is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is DiaMedica Therapeutics stock overvalued right now?

DiaMedica Therapeutics (DMAC) has a current Change In Inventory of $0.00 Mil. The current Change In Inventory is $0.00 Mil. DiaMedica Therapeutics' overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Change In Inventory calculated?

Change In Inventory is calculated from a company's financial statements. For DiaMedica Therapeutics (DMAC), the current Change In Inventory is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DiaMedica Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies PRLD RCKT TENX AVIR VNDA OABI CYDY UPB VSTM IRD VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 301 Carlson Parkway, Suite 210, Minneapolis, MN, USA, 55305

Website https://www.diamedica.com

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing treatment for ischemic diseases with two main clinical programs focused on acute ischemic stroke (AIS) and preeclampsia (PE). Its main product candidate DM199 (rinvecalinase alfa) is a recombinant form of human tissue kallikrein-1, which is a synthetic version of the naturally occurring protease enzyme kallikrein-1 and a rhKLK1 undergoing clinical development studies in both AIS and PE. The other product candidate in the company's pipeline is DM300, its patented recombinant human ulinastatin, a broad-spectrum serine protease inhibitor, being developed as a potential therapy for severe acute pancreatitis.

31GF Score

Get the complete analysis for DMAC

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.61

Price

View DMAC Analysis

See Change In Inventory data for all stocks →